Table III.
Correlation between Elf5 expression and clinicopathological parameters in epithelial ovarian cancer.
| Elf5 expression | ||||||
|---|---|---|---|---|---|---|
| Clinicopathological parameters | Total number of cases (n) | Negative | Positive | Positive rate (%) | χ2 value | P-value |
| Age (years) | ||||||
| <53 | 154 | 99 | 55 | 35.7 | 0.011 | 0.916 |
| ≥53 | 146 | 93 | 53 | 36.3 | ||
| Pathological type | ||||||
| Serous carcinoma | 168 | 106 | 62 | 36.9 | 0.153 | 0.985 |
| Mucinous carcinoma | 63 | 41 | 22 | 34.9 | ||
| Endometrial carcinoma | 54 | 35 | 19 | 35.2 | ||
| Clear cell carcinoma | 15 | 10 | 5 | 33.3 | ||
| FIGO staging | ||||||
| I–II | 143 | 78 | 65 | 45.6 | 10.601 | 0.001 |
| III–IV | 157 | 114 | 43 | 27.4 | ||
| Pathological staging | ||||||
| G1+G2 | 124 | 62 | 62 | 50.0 | 17.981 | <0.001 |
| G3 | 176 | 130 | 46 | 26.1 | ||
| Lymph node metastasis | ||||||
| Yes | 186 | 137 | 49 | 26.3 | 19.808 | <0.001 |
| No | 114 | 55 | 59 | 51.8 | ||